Replies to post #142786 on Biotech Values

[genisi]

GSK will present data from phase III of trametinib but its value in monotherpy is low

http://abstract.asco.org/AbstView_114_96304.html

The conbo is in phase III but i could only find an update from phase I/II to be presented in ASCO

http://abstract.asco.org/AbstView_114_97785.html